1037 ET - Hims & Hers Health logged heavy revenue gains in 3Q in part from its compounded weight-loss drug business, but the company's core telehealth business looked strong too, Piper Sandler analysts Korinne Wolfmeyer and Sarah Morin say in a research note. Management called out strong demand across the Hers platform, which focuses on women's health and personal care, as well as rising demand for personalized offerings and medications that treat multiple conditions at once, the analysts say. Stripping out the weight-loss business, the company's subscriber count in 3Q was still more than 40% higher year-over-year. (dean.seal@wsj.com)
(END) Dow Jones Newswires
November 05, 2024 10:37 ET (15:37 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。